Published in J Nutr on September 29, 2010
Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 2.41
Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988-2010. J Nutr (2012) 1.98
Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users. AIDS (2012) 1.41
Folate and vitamin B-12 biomarkers in NHANES: history of their measurement and use. Am J Clin Nutr (2011) 1.33
3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clin Chim Acta (2011) 1.19
Overview of a roundtable on NHANES monitoring of biomarkers of folate and vitamin B-12 status: measurement procedure issues. Am J Clin Nutr (2011) 1.16
Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001-2006. Diabetes Care (2012) 1.16
Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab (2011) 1.03
Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. PLoS One (2012) 0.96
The 25-hydroxyvitamin D3 C-3 epimer: distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC). Clin Chim Acta (2015) 0.95
Vitamin d deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes (2011) 0.94
Advances in standardization of laboratory measurement procedures: implications for measuring biomarkers of folate and vitamin B-12 status in NHANES. Am J Clin Nutr (2011) 0.94
The 3 epimer of 25-hydroxycholecalciferol is present in the circulation of the majority of adults in a nationally representative sample and has endogenous origins. J Nutr (2014) 0.90
Assessing vitamin status in large population surveys by measuring biomarkers and dietary intake - two case studies: folate and vitamin D. Food Nutr Res (2012) 0.89
Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey. Am J Clin Nutr (2015) 0.87
Life-course determinants of bone mass in young adults from a transitional rural community in India: the Andhra Pradesh Children and Parents Study (APCAPS). Am J Clin Nutr (2014) 0.84
High throughput LC-MS/MS method for the simultaneous analysis of multiple vitamin D analytes in serum. J Chromatogr B Analyt Technol Biomed Life Sci (2016) 0.82
Vitamin D and racial disparity in albuminuria: NHANES 2001-2006. Am J Hypertens (2011) 0.82
Vitamin D-related host genetic variants alter HIV disease progression in children. Pediatr Infect Dis J (2013) 0.81
The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases. Am J Clin Nutr (2016) 0.79
Rising trend in vitamin D status from 1993 to 2013: dual concerns for the future. Endocr Connect (2015) 0.78
Association of 25-Hydroxyvitamin D status and genetic variation in the vitamin D metabolic pathway with FEV1 in the Framingham Heart Study. Respir Res (2015) 0.78
A Review of Cutoffs for Nutritional Biomarkers. Adv Nutr (2016) 0.76
Calibration of High-Density Lipoprotein Cholesterol Values From the Korea National Health and Nutrition Examination Survey Data, 2008 to 2015. Ann Lab Med (2017) 0.75
Low serum vitamin D is associated with axial length and risk of myopia in young children. Eur J Epidemiol (2016) 0.75
Challenges and Lessons Learned in Generating and Interpreting NHANES Nutritional Biomarker Data. Adv Nutr (2017) 0.75
Vitamin D and uterine leiomyoma among a sample of US women: Findings from NHANES, 2001-2006. Reprod Toxicol (2015) 0.75
Value Assignment of Vitamin D Metabolites in Vitamin D Standardization Program Serum Samples. J AOAC Int (2017) 0.75
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival. Endocrine (2017) 0.75
Calcium intake and bone mineral density as an example of non-linearity and threshold analysis. Osteoporos Int (2015) 0.75
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem (2003) 6.77
Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab (2004) 6.41
Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr (2008) 6.26
C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab (2006) 3.59
How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem (2004) 3.30
Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol (2008) 3.17
HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem (2006) 3.16
Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem (2008) 3.14
Multi-rule quality control for the age-related eye disease study. Stat Med (2008) 2.89
Assessing the vitamin D status of the US population. Am J Clin Nutr (2008) 2.75
A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem (2000) 1.69
Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem (1997) 1.68
Reference materials and commutability. Clin Biochem Rev (2007) 1.62
25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem (2009) 1.24
Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin Chim Acta (2008) 1.21
1 alpha,25-(OH)2-vitamin D3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro. Arch Biochem Biophys (1996) 1.19
Accuracy verification and identification of matrix effects. The College of American Pathologists' Protocol. Arch Pathol Lab Med (1993) 1.07
The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays. J Steroid Biochem Mol Biol (2007) 1.07
Data advisory with regard to NHANES serum 25-hydroxyvitamin D data. Am J Clin Nutr (2009) 1.05
Reference materials and reference measurement procedures: an overview from a national metrology institute. Clin Biochem Rev (2007) 1.03
Summary of roundtable discussion on vitamin D research needs. Am J Clin Nutr (2008) 0.99
2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 (2002) 38.37
Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 33.23
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA (2004) 25.36
Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA (2002) 23.79
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07
The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05
Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics (2002) 12.32
Denosumab in postmenopausal women with low bone mineral density. N Engl J Med (2006) 10.02
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77
Extended work shifts and the risk of motor vehicle crashes among interns. N Engl J Med (2005) 8.73
Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care (2002) 8.22
Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med (2012) 8.19
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr (2002) 7.34
Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol (2004) 6.90
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr (2008) 6.26
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging (2005) 5.84
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med (2005) 5.78
Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA (2006) 5.53
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol (2011) 5.46
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest (2007) 5.38
Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol (2004) 5.23
Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr (2008) 5.01
Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst (2007) 4.89
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med (1990) 4.77
Dietary supplement use in the United States, 2003-2006. J Nutr (2010) 4.72
Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61
Secular trends in dietary intake in the United States. Annu Rev Nutr (2004) 4.59
Total folate and folic acid intake from foods and dietary supplements in the United States: 2003-2006. Am J Clin Nutr (2009) 4.57
Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke (2004) 4.56
Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Am J Med Genet A (2006) 4.56
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25
Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA (2005) 4.22
Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21
Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol (2005) 4.04
Comparison of risk factors for colon and rectal cancer. Int J Cancer (2004) 4.03
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum (2012) 4.01
Characterizing extreme values of body mass index-for-age by using the 2000 Centers for Disease Control and Prevention growth charts. Am J Clin Nutr (2009) 3.90
Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87
Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr (2010) 3.86
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63
Trends in lipids and lipoproteins in US adults, 1988-2010. JAMA (2012) 3.62
Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52
Development of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveys. Am J Clin Nutr (2003) 3.40
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
Relation between dieting and weight change among preadolescents and adolescents. Pediatrics (2003) 3.36
Performance in Measurement of Serum Cystatin C by Laboratories Participating in the College of American Pathologists 2014 CYS Survey. Arch Pathol Lab Med (2015) 3.36
Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA (2007) 3.34
Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med (2005) 3.26
Extended work duration and the risk of self-reported percutaneous injuries in interns. JAMA (2006) 3.26
Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study. Aging Cell (2008) 3.24
Impact of extended-duration shifts on medical errors, adverse events, and attentional failures. PLoS Med (2006) 3.22
Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science (2014) 3.14
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11
Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 3.11
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 3.11
Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07
Incident cognitive impairment is elevated in the stroke belt: the REGARDS study. Ann Neurol (2011) 3.06
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab (2002) 3.06
Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr (2007) 3.03
Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol (2005) 3.02
Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA (2013) 2.98
Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92
Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci (2008) 2.91
CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology (2008) 2.90
Multi-rule quality control for the age-related eye disease study. Stat Med (2008) 2.89
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke (2013) 2.88
Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev Cell (2010) 2.84
Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension (2013) 2.83
Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS Data Brief (2011) 2.82
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med (2006) 2.81
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2010) 2.78
Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol (2012) 2.75
Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann Neurol (2008) 2.68
Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr (2003) 2.68
Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66
Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. Mol Cell (2004) 2.55
The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res (2014) 2.52
Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol (2011) 2.50
Vitamin D status: United States, 2001-2006. NCHS Data Brief (2011) 2.50